Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Comprehensive protection of a patient with atrial fibrillation (AF) should not only reduce the risk of stroke and systemic embolism, but also reduce the risk coronary events and ensure high adherence to treatment. In accordance with consensus document issued by the European Heart Rhythm Association,...
Saved in:
Main Author: | A. V. Panov (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022) -
Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?
by: E. P. Panchenko
Published: (2020) -
Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention
by: V. А. Ryagina, et al.
Published: (2023) -
Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study
by: Kanako Fujita, et al.
Published: (2023) -
Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010)